Future Directions in ER+ Breast Cancer Research: What Lies Ahead?
Estrogen receptor-positive (ER+) breast cancer is a prevalent subtype of breast cancer, accounting for approximately 70% of cases. While significant advancements have been made in understanding and treating ER+ breast cancer, ongoing research aims to uncover new insights and improve patient outcomes. Here, we explore the future directions in ER+ breast cancer research and what…